Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-025663

Director acquired 359 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Salter Malcolm Director 2021-04-05 Grant or award +359 $37.51 $13,466 16,353 D
Loading xslF345X03/doc4.xml…